Eindhoven, North Brabant, Netherlands · On-site
$55k–$75k/yr
Your mission Do you have a strong track record in clinical studies within the medical device industry and are you motivated to lead studies that make real impact for patients? Are you motivated by the idea of bringing br…
Skills: Clinical Trial Management, Medical Device Regulations, ICH-GCP, ISO 14155, CRO Coordination
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
Lead the execution of clinical studies for neuromodulation therapy from planning through close-out. Coordinate with CROs and cross-functional teams to ensure compliance with quality standards and regulatory requirements.
Requires a degree in Life Sciences or a related field with at least 5 years of experience in clinical research, specifically within the medical device industry. Must be fluent in English and Dutch and reside near Eindhoven.
Salvia BioElectronics is pioneering a novel neuromodulation therapy for people with debilitating migraine.
Salvia BioElectronics is pioneering a novel neuromodulation therapy for resistant migraine*. MySalvia Therapy features ultra-thin implants, designed to target key nerves involved in migraine, and is activated by the press of a button on a wearable device. Built for everyday life, it is currently being evaluated in clinical studies. Our commitment is to work toward a future of drug-free relief without compromise, so people with migraine can live life, uninterrupted. Founded in 2017 in Europe’s tech capital Eindhoven, Salvia brings together skilled device makers and MedTech entrepreneurs with extensive experience in medical devices and neuromodulation. Active in the United States and Europe, the company is advancing clinical development with the support of leading investors. Salvia is also exploring the potential of its technology for the treatment of cluster headache. *Resistant migraine is a condition in which significant disability persists despite multiple preventive treatments and is common among people living with chronic migraine.
Offices: High Tech Campus 37, Eindhoven, North Brabant 5656 AE, NL
Salvia BioElectronics is pioneering a novel neuromodulation therapy for people with debilitating migraine.
Salvia BioElectronics is pioneering a novel neuromodulation therapy for resistant migraine*. MySalvia Therapy features ultra-thin implants, designed to target key nerves involved in migraine, and is activated by the press of a button on a wearable device. Built for everyday life, it is currently being evaluated in clinical studies. Our commitment is to work toward a future of drug-free relief without compromise, so people with migraine can live life, uninterrupted. Founded in 2017 in Europe’s tech capital Eindhoven, Salvia brings together skilled device makers and MedTech entrepreneurs with extensive experience in medical devices and neuromodulation. Active in the United States and Europe, the company is advancing clinical development with the support of leading investors. Salvia is also exploring the potential of its technology for the treatment of cluster headache. *Resistant migraine is a condition in which significant disability persists despite multiple preventive treatments and is common among people living with chronic migraine.
Offices: High Tech Campus 37, Eindhoven, North Brabant 5656 AE, NL
